Scientific Research
Arthritis is Australia’s leading cause of disability and chronic pain.
Our ageing population shows a high incidence of Arthritis with over 3.85 million people suffering. We lose 213,000 work or school days a year due to Arthritis pain and disability with over 8.5 million visits to doctors (GPs), 2.2 million specialist visits and 1.4 million visits to other health practitioners. (source: MIS data 2000)
There is now Clinically Tested Arthritis relief
Rose-Hip Vital undertakes regular research and testing to see how many people benefit from taking it and find out their improvements. Some of the remarkable effects proven in laboratory testing include:
- reduction of leukocyte migration (anti inflammatory)
- reduction of oxidative burst response leukocytes (anti-oxidant)
- reduction of the level of the inflammatory marker CRP
- preservation of cell membrane
Dr Kaj Winther, MD, DMSci, from the department of Clinical Biochemistry, Fredricksberg Hospital, University of Copenhagen, Denmark, has been involved in researching and testing Rose-Hip for over a decade.
How Rose-Hip Vital beats ordinary Vitamin C
Clinical trials show that Rose-Hip Vital’s natural Vitamin C is absorbed more effectively than the synthetic version due to its high concentration.
Blood levels for Vitamin C were measured 2 and 4 hours after ingestion.
500 mgs (one capsule) still climbing after 4 hours!
AIM: Study reduction of pain and stiffness of Osteoarthritic joints to see whether Rose-Hip Vital would improve daily activities or quality of life of patients.
112 patients with Osteoarthritis of the hip, knee, neck or wrist were randomly allocated treatment with either Rose-Hip Vital or a placebo for a total of six months. In this double-blind cross-over test, Group A received 5 placebo capsules twice daily for 3 months, then switched to capsules with Rose-Hip Vital for another 3 months; vice-versa Group B.
CONCLUSION: Data suggests that Rose-Hip Vital significantly reduces pain and stiffness and augments general well-being in patients with Osteoarthritis. Results also suggest the action of Rose-Hip Vital is protracted.
Our Research Continues
On top of the many success stories and anecdotal evidence of its effectiveness in treating Arthritis, Osteoarthritis and Rheumatoid Arthritis, we put Rose-Hip Vital under the scientific microscope. As with conventional medical trials, we ran a series of controlled double-blind placebo tests.
Before the trials we were confident…and the results were very positive. Here are four completed clinical trials. Initial results are beyond all expectations.
Scientific Journal reports
Please click on the report to open
24-Sep-2009-OARSI-study-glucosomine-vs-rosehips
29-Sept-2009-RHV-research-pain-clinical-pathophysiology
2008. Anti-inflammatory and anti-oxidant properties of rose hip powder - Copenhagen, Denmark
2007-December 6-9-World Congress on Osteoarthritis - Ft. Lauderdale, Florida
2007-June 13-16 - Annual European Congress of Rheumatology - Barcelona, Spain
2006-December 7-10 - World Congress on Osteoarthritis – Prague, Czech Republic
March 22-24, 2006. Nutracon - Anaheim, USA
December 8-11, 2005. Osteoarthritis and Cartilage - Boston, USA
March 16-19, 2005. Osteoporosis International 5th European Congress - Rome, Italy
December 2-5, 2004. 9th World Congress of the OsteoArthritis Reserch Society International
June 2-5, 2004. Scandinavian Journal of Gastroenterology. Volume 39, Supplement 240.
April 24-27, 2004. The XXIX Nordic Congress in Clinical Chemistry - Malmo, Sweden
January 20, 2004. Phytomedicine
January 2003. Current Therapeutic Research, Volume 65, Number 1
August 2002. 29th Scandinavian Congress of Rheumatology - Tromsø, Norway
June 2002. 10th World Congress on the Menopause - Berlin, Germany
June 10-15, 2002. European Congress On Osteoarthritis - Stockholm, Sweden
September 19-22 2001. 30th German Congress On Rheumatology - Leipzig, Germany
June 10 - 15, 2001. International Council of Nurses ICN 22nd Quadrennial Congress - Copenhagen.
September 2000. Hyben Vital, a standardised powder made from Rose-hip - Tønsberg, Norway
September 13 -16 , 2000. Kongress der Deutschen Gesellschaft für Rheumatologie
May 2000. Impact on coagulation platelet function and fibrinolysis - Denmark
May 21-26, 2000. 6th National Congress On Rheumatology - Beijing, China
May 10-13, 2000. 3rd CENTRAL EUROPEAN CONGRESS OF RHEUMATOLOGY - Bratislava, Slovakia
May 16-19 1999. Congress on Heart Disease - Washington, USA
February 5, 1999. The anti-inflammatory properties of rose-hip. Inlammopharmacology, Volume 7, No. 1
October 18-21 1998. 2nd International Congress on Coronary Artery Disease - Florence, Italy
September 21-24, 1997. 1st International Congress on Coronary Artery Disease - Prague Czezh Republic
